Literature DB >> 11996245

Long-term results after pulmonary resection of renal cell carcinoma metastases.

Stefan Piltz1, Georgios Meimarakis, Matthias W Wichmann, Rudolf Hatz, Friedrich Wilhelm Schildberg, Heinrich Fuerst.   

Abstract

BACKGROUND: Until now no conclusive data exist regarding the factors influencing long-term survival after pulmonary resection of renal cell carcinoma metastases. The aim of the present study, therefore, was to discover definitive prognostic factors for survival using a large and homogeneous single center patient cohort.
METHODS: Between 1980 and 2000, 105 patients, after curative resection of lung metastases from renal cell carcinoma, were followed in this long-term study. These patients underwent a total of 150 surgical procedures. Survival analysis was done using the Kaplan-Meier method and the log-rank test. Multivariate analysis of prognostic factors was performed using the Cox multivariate proportional hazard model.
RESULTS: Median survival after curative resection reached 43 months (range, 1 to 218 months). Survival at 3, 5, and 10 years was 54%, 40%, and 33%, respectively. Univariate analysis revealed that a complete resection, a less than 4-cm diameter of the metastases and tumor-free lymph nodes at the time of primary operation, were highly significant dependent prognostic factors (p < 0.001). These factors were also shown to be independent prognostic factors as suggested by multivariate analysis (p < 0.05).
CONCLUSIONS: The size of the metastatic nodule, the completeness of pulmonary resection, and the lymph node status at the time of nephrectomy are the most important prognostic factors that influence survival after resection of pulmonary metastases. Recurrence of resectable pulmonary metastases does not impair survival, thus favoring repeated resection in patients with recurrent disease.

Entities:  

Mesh:

Year:  2002        PMID: 11996245     DOI: 10.1016/s0003-4975(01)03602-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  48 in total

Review 1.  [Metastasectomy for renal cell cancer].

Authors:  B Brehmer; C Piper; D Pfister; D Porres; A Heidenreich
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

2.  Evaluation of video-assisted thoracoscopic surgery for pulmonary metastases: 11-years of experience.

Authors:  Shinsuke Saisho; Masao Nakata; Shigeki Sawada; Motohiro Yamashita; Hideyuki Saeki; Akira Kurita; Shigemitsu Takashima
Journal:  Surg Endosc       Date:  2008-04-24       Impact factor: 4.584

3.  Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients.

Authors:  Y A M Kuijpers; R P Meijer; G N Jonges; J de Jong; J L H R Bosch; S Horenblas; A Bex
Journal:  World J Urol       Date:  2016-04-07       Impact factor: 4.226

Review 4.  Is there a role for systemic targeted therapy after surgical treatment for metastases of renal cell carcinoma?

Authors:  Adrian Husillos Alonso; Manuel Carbonero García; Carmen González Enguita
Journal:  World J Nephrol       Date:  2015-05-06

5.  Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.

Authors:  Ricardo A Rendon; Anil Kapoor; Rodney Breau; Michael Leveridge; Andrew Feifer; Peter C Black; Alan So
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 6.  New challenges in kidney cancer management: integration of surgery and novel therapies.

Authors:  Javier Puente Vázquez; T Alonso Gordoa; J Moreno; L Poma; E Diaz Rubio; A Gomez; J Blazquez; J L Gonzalez Larriba
Journal:  Curr Treat Options Oncol       Date:  2015-03

Review 7.  [When is aftercare useful in renal cell cancer?].

Authors:  T Ebert; C Fischer
Journal:  Urologe A       Date:  2005-09       Impact factor: 0.639

8.  Histology is a Prognostic Indicator After Pulmonary Metastasectomy from Renal Cell Carcinoma.

Authors:  Yoichi Ohtaki; Kimihiro Shimizu; Keiju Aokage; Masayuki Nakao; Junji Yoshida; Mitsuhiro Kamiyoshihara; Masayuki Sugano; Yusuke Takahashi; Seshiru Nakazawa; Toshiteru Nagashima; Kai Obayashi; Tomoyuki Hishida; Masahiro Tsuboi; Shohei Mori; Mingyon Mun; Sakae Okumura; Hitoshi Igai; Noriyuki Matsutani; Akira Mogi; Hiroyuki Kuwano
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

Review 9.  Surgical resection of urological tumor metastases following medical treatment.

Authors:  Axel Heidenreich; Stefan Wilop; Michael Pinkawa; Daniel Porres; David Pfister
Journal:  Dtsch Arztebl Int       Date:  2012-09-28       Impact factor: 5.594

10.  Chest X-ray in the follow-up of renal cell carcinoma.

Authors:  B H J Doornweerd; I J de Jong; L M Bergman; H J K Ananias
Journal:  World J Urol       Date:  2013-10-06       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.